Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy
Cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation (HSCT) is one of the critical infectious complications related to host immune recovery. The spectrum of CMV infection is quite extensive, from asymptomatic CMV reactivation presenting mainly as CMV DNAemia to fatal CMV dis...
Main Authors: | Sung-Yeon Cho, Dong-Gun Lee, Hee-Je Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/11/2666 |
Similar Items
-
Mutations in the cytomegalovirus UL97 gene associated with ganciclovir resistance in recipients of allogeneic hematopoietic stem cell transplants
by: Demin M.V., et al.
Published: (2019-12-01) -
The association of conditioning regimen with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
by: Masoud Mardani, et al.
Published: (2020-12-01) -
Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient
by: Susanne Jung, et al.
Published: (2019-05-01) -
Risk factors and outcomes of cytomegalovirus viremia in pediatric hematopoietic stem cell transplantation patients
by: Jhong-Lin Wu, et al.
Published: (2017-06-01) -
Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein–Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant
by: Ndeye Soukeyna Diop, et al.
Published: (2021-06-01)